2011
DOI: 10.1007/s00213-011-2600-1
|View full text |Cite
|
Sign up to set email alerts
|

Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression

Abstract: Our results point to a lateralized modulatory effect of VIP injected in the hippocampal CA1 area on the avoidance deficits in OBX rats. The right CA1 area was predominantly involved in the positive effect of VIP on learning and memory. A possible role of the PAC1 receptors is suggested.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 71 publications
1
7
1
Order By: Relevance
“…Finally, we found no statistically significant change in CCK or VIP mRNA levels in the PFC or HPC. This was in contrast with the reported increased in CCK levels in the cortex 94,95 and decreased VIP expression in specific sub-regions of the HPC 96 following chronic stress.…”
Section: Discussioncontrasting
confidence: 99%
“…Finally, we found no statistically significant change in CCK or VIP mRNA levels in the PFC or HPC. This was in contrast with the reported increased in CCK levels in the cortex 94,95 and decreased VIP expression in specific sub-regions of the HPC 96 following chronic stress.…”
Section: Discussioncontrasting
confidence: 99%
“…VIP participates in the pathophysiology of several neurological disorders associated with cognitive disfunction, like depression (Ivanova et al, 2012), autism spectrum disorders, Alzheimer's disease (AD), Parkinson's disease (PD) and epilepsy (de Lanerolle et al, 1995;Hill, 2007;White et al, 2010). Due to its anti-apoptotic, anti-inflammatory and neuroprotective actions, VIP and its receptors constitute promising therapeutic targets in many of these pathologies (Gozes, 2001;Delgado et al, 2002;Yu et al, 2017).…”
Section: Vip In Cognitive Processesmentioning
confidence: 99%
“…The alteration of VIP release and/or the VIP binding receptors could be potentially implicated in multiple pathophysiological conditions. It has been shown that the VIP peptide has a significant role in regulating neuronal activity, and the selective loss of this peptide is associated with several pathological disorders such as depression ( Ivanova et al, 2012 ), Parkinson’s disease, and epilepsy ( Hill, 2007 ; White et al, 2010 ). Indeed, in human temporal lobe epilepsy brains, the receptors for the VIP peptide are increased in expression in the focus of the seizure.…”
Section: The Role Of Vip-expressing Neurons In Cortical Dysfunctionmentioning
confidence: 99%